A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection

被引:155
作者
Assarsson, Erika
Sidney, John
Oseroff, Carla
Pasquetto, Valerie
Bui, Huynh-Hoa
Frahm, Nicole
Brander, Christian
Peters, Bjoern
Grey, Howard
Sette, Alessandro
机构
[1] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA
[2] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02116 USA
[3] Harvard Univ, Sch Med, Div Aids, Boston, MA 02115 USA
关键词
D O I
10.4049/jimmunol.178.12.7890
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many components contribute to immunodominance in the response to a complex virus, but their relative importance is unclear. This was addressed using vaccinia virus and HLA-A*0201 as the model system. A comprehensive analysis of 18 viral proteins recognized by CD8(+) T cell responses demonstrated that approximately one-fortieth of all possible 9- to 10-mer peptides were high-affinity HLA-A*0201 binders. Peptide immunization and T cell recognition data generated from 90 peptides indicated that about one-half of the binders were capable of eliciting T cell responses, and that one-seventh of immunogenic peptides are generated by natural processing. Based on these results, we estimate that vaccinia virus encodes similar to 150 dominant and subdominant epitopes restricted in by HLA-A*0201. However, of all these potential epitopes, only 15 are immunodominant and actually recognized in vivo during vaccinia virus infection of HLA-A*0201 transgenic mice. Neither peptide-binding affinity, nor complex stability, nor TCR avidity, nor amount of processed epitope appeared to strictly correlate with immunodominance status. Additional experiments suggested that vaccinia infection impairs the development of responses directed against subdominant epitopes, This suggested that additional factors, including immunoregulatory mechanisms, restrict the repertoire of T cell specificities after vaccinia infection by a factor of at least 10.
引用
收藏
页码:7890 / 7901
页数:12
相关论文
共 64 条
[1]   MECHANISMS INFLUENCING THE IMMUNODOMINANCE OF T-CELL DETERMINANTS [J].
ADORINI, L ;
APPELLA, E ;
DORIA, G ;
NAGY, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (06) :2091-2104
[2]   Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses [J].
Andreansky, SS ;
Stambas, J ;
Thomas, PG ;
Xie, WD ;
Webby, RJ ;
Doherty, PC .
JOURNAL OF VIROLOGY, 2005, 79 (07) :4329-4339
[3]   THE ESSENCE OF EPITOPES [J].
BARBER, LD ;
PARHAM, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1191-1194
[4]   THE RESPONSE TO H-2-DIFFERENT VIRUS-INFECTED CELLS IS MEDIATED BY LONG-LIVED LYMPHOCYTES-T AND IS DIMINISHED BY PRIOR VIRUS PRIMING IN A SYNGENEIC ENVIRONMENT [J].
BENNINK, JR ;
DOHERTY, PC .
CELLULAR IMMUNOLOGY, 1981, 61 (01) :220-224
[5]   IMMUNODOMINANCE IN LYMPHOCYTE-T RECOGNITION [J].
BERZOFSKY, JA .
IMMUNOLOGY LETTERS, 1988, 18 (02) :83-92
[6]   Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses [J].
Bihl, Florian ;
Frahm, Nicole ;
Di Giammarino, Loriana ;
Sidney, John ;
John, Mina ;
Yusim, Karina ;
Woodberry, Tonia ;
Sango, Kaori ;
Hewitt, Hannah S. ;
Henry, Leah ;
Linde, Caitlyn H. ;
Chisholm, John V., III ;
Zaman, Tauheed M. ;
Pae, Eunice ;
Mallal, Simon ;
Walker, Bruce D. ;
Sette, Alessandro ;
Korber, Bette T. ;
Heckerman, David ;
Brander, Christian .
JOURNAL OF IMMUNOLOGY, 2006, 176 (07) :4094-4101
[7]   HLA-A2-restricted protection against lethal lymphocytic choriomeningitis [J].
Botten, Jason ;
Whitton, J. Lindsay ;
Barrowman, Polly ;
Sidney, John ;
Whitmire, Jason K. ;
Alexander, Jeff ;
Ting, Joey P. C. ;
Bui, Huynh-Hoa ;
Sette, Alessandro ;
Buchmeier, Michael J. .
JOURNAL OF VIROLOGY, 2007, 81 (05) :2307-2317
[8]  
Cao WX, 1996, J IMMUNOL, V157, P505
[9]   Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses [J].
Chen, WS ;
Antón, LC ;
Bennink, JR ;
Yewdell, JW .
IMMUNITY, 2000, 12 (01) :83-93
[10]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099